Mirae Asset TIGER NASDAQ Bio ETF (KRX:203780)

South Korea flag South Korea · Delayed Price · Currency is KRW
32,250
-665 (-2.02%)
Jun 2, 2026, 3:30 PM KST
Assets89.48B
Expense Ratio0.30%
PE Ratio20.39
Dividend (ttm)160.00
Dividend Yield0.49%
Ex-Dividend DateDec 29, 2025
Payout FrequencyAnnual
Payout Ratio9.97%
1-Year Return+54.37%
Volume24,705
Open32,200
Previous Close32,915
Day's Range31,950 - 32,250
52-Week Low20,635
52-Week High33,155
Beta-0.01
Holdings10
Inception DateAug 26, 2014

About 203780

Mirae Asset TIGER NASDAQ Bio ETF is an exchange traded fund launched and managed by Mirae Asset Investments Co., Ltd. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of companies across all market capitalizations with a minimum market capitalization of $200 million. It seeks to replicate the performance of the NASDAQ Biotechnology Index (Price Return), by investing in stocks of companies as per their weightings in the Index. Mirae Asset TIGER NASDAQ Bio ETF was formed on August 27, 2014 and is domiciled in South Korea.

Asset Class Equity
Category Health Care
Stock Exchange Korea Stock Exchange
Ticker Symbol 203780
Provider Tiger ETF
Index Tracked NASDAQ / Biotechnology

Performance

203780 had a total return of 54.37% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.59%.

Top Holdings

39.82% of assets
NameSymbolWeight
Gilead Sciences, Inc.GILD7.25%
Vertex Pharmaceuticals IncorporatedVRTX7.11%
Amgen Inc.AMGN7.00%
Regeneron Pharmaceuticals, Inc.REGN5.12%
Alnylam Pharmaceuticals, Inc.ALNY3.08%
Revolution Medicines, Inc.RVMD2.38%
Biogen Inc.BIIB2.27%
United Therapeutics CorporationUTHR1.96%
argenx SEARGX1.83%
Royalty Pharma plcRPRX1.82%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 29, 2025160.000 KRWJan 5, 2026
Dec 27, 202410.000 KRWJan 3, 2025
Dec 27, 202330.000 KRWJan 3, 2024
Dec 28, 202210.000 KRWJan 3, 2023
Dec 29, 20215.000 KRWJan 4, 2022
Dec 29, 202010.000 KRWJan 5, 2021
Full Dividend History